
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Set1B CRISPR/Cas9 KO Plasmid (m) | sc-431532 | 20 µg | $397.00 |
Setd1b encodes the Set1B histone lysine methyltransferase, a core component of COMPASS-like chromatin-modifying complexes that catalyze H3K4 methylation at active promoters and regulatory elements. Through modulation of H3K4me1/2/3 states, Set1B helps coordinate transcription initiation, RNA polymerase II activity, and epigenetic maintenance of cell identity programs. Setd1b-dependent chromatin regulation is linked to developmental and neuronal gene expression networks, and altered SETD1B function is associated with neurodevelopmental phenotypes and broader epigenetic dysregulation relevant to disease biology. In mouse systems, Set1B provides a tractable target for dissecting how promoter-associated histone methylation shapes signaling-responsive transcription and genome-wide chromatin landscapes.
Set1B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Setd1b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Setd1b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Setd1b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Set1B protein expression.
This CRISPR knockout system enables efficient generation of Setd1b-deficient cell models for investigation of Set1B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.